ASTRO Journals
Stay current with the latest studies in radiation oncology with free podcasts from the official journals of the American Society for Radiation Oncology (ASTRO). The International Journal of Radiation Oncology-Biology-Physics (the Red Journal) publishes the latest clinical research related to radiation oncology, radiation biology, medical physics, education, and health policy. The overarching mission of Practical Radiation Oncology is to improve the quality of radiation oncology practice through publication of official ASTRO guidelines and white papers, discussion and illustration of new techniques, evaluation of current practices, and publication of case reports. Advances in Radiation Oncology is a wide-ranging clinical research journal whose articles are free and open for all to read. Visit www.redjournal.org, www.practicalradonc.org, and www.advancesradonc.org to learn more about ASTRO's journals.
ASTRO Journals
“SBRT clinical trials: Selections from the editors” – Red Journal podcast May 1, 2026
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Editor-in-Chief Sue Yom hosts three editors who pick highlights from the special issue! Dr. Nicholas Zaorsky is Professor in the Department of Radiation Oncology at Case Comprehensive Cancer Center and Vice Chair of Education and Director of Genitourinary Oncology at University Hospitals in Cleveland. Dr. Michelle Kim, Professor in the Department of Radiation Oncology and Co-Chair of the Cancer Center Neuro-Oncology Clinical Research Team at the University of Michigan, is the section chief for Brain and Spine at the Red Journal. Dr. Bethany Anderson, Professor at the University of Wisconsin School of Medicine and Public Health in the Department of Human Oncology and specialist in breast and gynecologic cancer treatment, is our Breast cancer section editor.
Dr. Zaorsky’s picks are: Stereotactic Body Radiation Therapy to the Prostate With Focal Boost: Analysis of the Primary Endpoint in the DELINEATE Trial Cohort E; PSMA-PET-Guided Intraprostatic Boost in Prostate SBRT (PROBE): A Phase 2 Trial; Two-Year Outcomes of the SPARC Phase II Trial: Simultaneous Focal Boost With Stereotactic Radiation Therapy for Localized Prostate Cancer; The Kilovoltage Intrafraction Monitoring Real-Time Prostate Cancer Image Guided Radiation Therapy Technology Journey: From Clinical Trials to Your Clinic; International Radiosurgery Oncology Consortium of the Kidney (IROCK) Contouring Guidelines for Renal Cell Carcinoma Treated With Stereotactic Ablative Radiation Therapy; Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical Trial; Efficacy of SABR in Uncommon Subtypes of Primary Kidney Cancer: An Analysis From the International Radiosurgery Oncology Consortium of the Kidney; SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial; A Prospective Study of Stereotactic Body Radiation Therapy in Oligometastatic Renal Cell Carcinoma; and Stereotactic Body Radiation Therapy for Oligoprogressive Disease in Androgen-Suppressed Prostate Cancer: Primary Endpoint Analysis of the TRAP Trial.
Dr. Kim’s picks are: Long-term Results From a Phase 1 Study of Spinal Cord Constraint Relaxation With Single Session Spine Stereotactic Radiosurgery in the Primary Management of Patients With Inoperable, Previously Unirradiated Spinal Metastases With Epidural Extension; Direct-to-Unit Stereotactic Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy for Spine Metastasis; Treatment With Stereotactic Ablative Radiation Therapy for Patients With up to 5 Oligometastatic Cancer Lesions: Long-Term Outcomes of the Nonrandomized Population-based Phase 2 SABR-5 Clinical Trial; and Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiation Therapy for Oligometastatic Disease: A Secondary Analysis of the Phase 2 SABR-5 Trial.
Dr. Anderson’s picks are: A Study of Curative-approach Treatment Along With Metastasis-Directed Stereotactic Body Radiation Therapy in Bone-Only Oligometastatic Breast Cancer; Long-Term Results of a Phase 2 Prospective Clinical Trial of Single-Fraction, High-Gradient Adjuvant Partial Breast Irradiation in Early-Stage, Hormone-Positive Breast Cancer; and Postoperative Single-Fraction Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer With GammaPod Technology: A Phase 2 Clinical Trial.